by Leanne Talbot | Mar 25, 2021
RESEARCH SPOTLIGHT MARCH 2021 – CLINICAL TRIALS IN NEUROENDOCRINE CANCER. Patient and public involvement (PPI) in research is a very welcome and increasingly frequent requirement due to the potential benefits in the design of participant and researcher relevant,... by Leanne Talbot | Mar 18, 2021
Neuroendocrine Cancer is often small, starting out the size of a grain of sand. Often it is not visible to the most accurate scans until it gets to about half a centimetre across or the size of a pea. It can occur in various parts of your body and spread to different... by Leanne Talbot | Mar 10, 2021
22nd March 14:00 (GMT) | 15:00 (CET) | 09:00 (EST) – NCRI-ICRP: Addressing disparities in international cancer research Event https://conference.ncri.org.uk/ncri-icrp-addressing-disparities-in-international-cancer-research/ This session, jointly organised with... by Leanne Talbot | Mar 10, 2021
Using an integrated approach combining data generated through the use of different, advanced molecular tools, we have previously demonstrated that neuroendocrine tumours of the pancreas and gastrointestinal tract are highly epigenetically dysregulated and have... 
